Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-Fluorouracil

PLoS Biology

Volumn 7, Issue 4, 2009, Pages 0967-0979

  Kunz, Christophe ^a   Focke, Frauke ^a   Saito, Yusuke ^a   Schuermann, David ^a   Lettieri, Teresa ^b   Selfridge, Jim ^c   Schär, Primo ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; THYMINE DNA GLYCOSYLASE; URACIL DNA GLYCOSIDASE;

ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME INACTIVATION; EXCISION REPAIR; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN FUNCTION;

MAMMALIA;

EID: 65949089155     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371-journal.pbio.1000091-S     Document Type: Article

References (53)

1. Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, et al. (1957) Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179: 663-666.
2. Longley DB, Harkin DP, Johnston PG (2003) 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3: 330-338.
3. Copur S, Aiba K, Drake JC, Allegra CJ, Chu E (1995) Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem Pharmacol 49: 1419-1426.
4. Johnston PG, Drake JC, Trepel J, Allegra CJ (1992) Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res 52: 4306-4312.
5. Peters GJ, Backus HH, Freemantle S, van Triest B, Codacci-Pisanelli G, et al. (2002) Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta 1587: 194-205.
6. Santi DV, McHenry CS, Sommer H (1974) Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 13: 471-481.
7. Sommer H, Santi DV (1974) Purification and amino acid analysis of an active site peptide from thymidylate synthetase containing covalently bound 5-fluoro-2'-deoxyuridylate and methylenetetrahydrofolate. Biochem Biophys Res Commun 57: 689-695.
8. Ingraham HA, Tseng BY, Goulian M (1982) Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine. Mol Pharmacol 21: 211-216.
9. An Q, Robins P, Lindahl T, Barnes DE (2007) 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity. Cancer Res 67: 940-945.
10. van der Wilt CL, Smid K, Aherne GW, Noordhuis P, Peters GJ (1997) Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells. Eur J Cancer 33: 471-478.
11. Peters GJ, van Triest B, Backus HH, Kuiper CM, van der Wilt CL, et al. (2000) Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed. Eur J Cancer 36: 916-924.
12. Fischer JA, Muller-Weeks S, Caradonna SJ (2006) Fluorodeoxyuridine modulates cellular expression of the DNA base excision repair enzyme uracil-DNA glycosylase. Cancer Res 66: 8829-8837.
13. Nilsen H, Rosewell I, Robins P, Skjelbred CF, Andersen S, et al. (2000) Uracil-DNA glycosylase (UNG) -deficient mice reveal a primary role of the enzyme during DNA replication. Mol Cell 5: 1059-1065.
14. Welsh SJ, Hobbs S, Aherne GW (2003) Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition. Eur J Cancer 39: 378-387.
15. Andersen S, Heine T, Sneve R, Konig I, Krokan HE, et al. (2005) Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts. Carcinogenesis 26: 547-555.
16. Kavli B, Sundheim O, Akbari M, Otterlei M, Nilsen H, et al. (2002) hUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup. J Biol Chem 277: 39926-39936.
17. Cortazar D, Kunz C, Saito Y, Steinacher R, Schar P (2007) The enigmatic thymine DNA glycosylase. DNA Repair (Amst) 6: 489-504.
18. Petronzelli F, Riccio A, Markham GD, Seeholzer SH, Stoerker J, et al. (2000) Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase. J Biol Chem 275: 32422-32429.
19. Turner DP, Cortellino S, Schupp JE, Caretti E, Loh T, et al. (2006) The DNA N-glycosylase MED1 exhibits preference for halogenated pyrimidines and is involved in the cytotoxicity of 5-iododeoxyuridine. Cancer Res 66: 7686-7693.
20. Cortellino S, Turner D, Masciullo V, Schepis F, Albino D, et al. (2003) The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. Proc Natl Acad Sci U S A 100: 15071-15076.
21. Neddermann P, Jiricny J (1993) The purification of a mismatch-specific thymine-DNA glycosylase from HeLa cells. J Biol Chem 268: 21218-21224.
22. Hardeland U, Bentele M, Jiricny J, Schar P (2003) The versatile thymine DNA-glycosylase: a comparative characterization of the human, Drosophila and fission yeast orthologs. Nucleic Acids Res 31: 2261-2271.
23. Hardeland U, Bentele M, Jiricny J, Schar P (2000) Separating substrate recognition from base hydrolysis in human thymine DNA glycosylase by mutational analysis. J Biol Chem 275: 33449-33456.
24. Fischer F, Baerenfaller K, Jiricny J (2007) 5-Fluorouracil is efficiently removed from DNA by the base excision and mismatch repair systems. Gastroenterology 133: 1858-1868.
25. Meyers M, Wagner MW, Mazurek A, Schmutte C, Fishel R, et al. (2005) DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. J Biol Chem 280: 5516-5526.
26. Meyers M, Wagner MW, Hwang HS, Kinsella TJ, Boothman DA (2001) Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidinemediated cell death and cell cycle responses. Cancer Res 61: 5193-5201.
27. Carethers JM, Chauhan DP, Fink D, Nebel S, Bresalier RS, et al. (1999) Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 117: 123-131.
28. Aebi S, Fink D, Gordon R, Kim HK, Zheng H, et al. (1997) Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res 3: 1763-1767.
29. Ozer HL, Banga SS, Dasgupta T, Houghton J, Hubbard K, et al. (1996) SV40-mediated immortalization of human fibroblasts. Exp Gerontol 31: 303-310.
30. Chang F, Syrjanen S, Kurvinen K, Syrjanen K (1993) The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 88: 174-186.
31. Bellacosa A (2001) Role of MED1 (MBD4) gene in DNA repair and human cancer. J Cell Physiol 187: 137-144.
32. Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A (1999) The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401: 301-304.
33. Hardeland U, Kunz C, Focke F, Szadkowski M, Schar P (2007) Cell cycle regulation as a mechanism for functional separation of the apparently redundant uracil DNA glycosylases TDG and UNG2. Nucleic Acids Res 35: 3859-3867.
34. Haug T, Skorpen F, Aas PA, Malm V, Skjelbred C, et al. (1998) Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase. Nucleic Acids Res 26: 1449-1457.
35. Fischer JA, Muller-Weeks S, Caradonna S (2004) Proteolytic degradation of the nuclear isoform of uracil-DNA glycosylase occurs during the S phase of the cell cycle. DNA Repair (Amst) 3: 505-513.
36. Caldecott KW (2003) XRCC1 and DNA strand break repair. DNA Repair (Amst) 2: 955-969.
37. El-Khamisy SF, Masutani M, Suzuki H, Caldecott KW (2003) A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res 31: 5526-5533.
38. Robinson HM, Jones R, Walker M, Zachos G, Brown R, et al. (2006) Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil. Oncogene 25: 5359-5369.
39. Xiao Z, Xue J, Sowin TJ, Rosenberg SH, Zhang H (2005) A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation. Oncogene 24: 1403-1411.
40. Zhao H, Piwnica-Worms H (2001) ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 21: 4129-4139.
41. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A (2004) H2AX: the histone guardian of the genome. DNA Repair (Amst) 3: 959-967.
42. Pettersen HS, Sundheim O, Gilljam KM, Slupphaug G, Krokan HE, et al. (2007) Uracil-DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms. Nucl Acids Res 35: 3879-3892.
43. Steinacher R, Schär P (2005) Functionality of human thymine DNA glycosylase requires SUMO-regulated changes in protein conformation. Curr Biol 15: 616-623.
44. Hardeland U, Steinacher R, Jiricny J, Schar P (2002) Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J 21: 1456-1464.
45. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA (2002) Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 36: 617-656.
46. Xiao Z, Xue J, Semizarov D, Sowin TJ, Rosenberg SH, et al. (2005) Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics. Int J Cancer 115: 528-538.
47. Chen Y, Sanchez Y. (2004) Chk1 in the DNA damage response: conserved roles from yeasts to mammals. DNA Repair (Amst) 3: 1025-1032.
48. Jaremko M, Justenhoven C, Schroth W, Abraham BK, Fritz P, et al. (2007) Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil- based chemotherapy of patients with primary invasive breast cancer. Pharmacogenet Genomics 17: 529-538.
49. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA (1999) XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59: 2557-2561.
50. Ostling O, Johanson KJ (1984) Microelectrophoretic study of radiationinduced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 123: 291-298.
51. Singh NP, Tice RR, Stephens RE, Schneider EL (1991) A microgel electrophoresis technique for the direct quantitation of DNA damage and repair in individual fibroblasts cultured on microscope slides. Mutat Res 252: 289-296.
52. Frieauff W, Hartmann A, Suter W (2001) Automatic analysis of slides processed in the Comet assay. Mutagenesis 16: 133-137.
53. Duez P, Dehon G, Kumps A, Dubois J. (2003) Statistics of the Comet assay: a key to discriminate between genotoxic effects. Mutagenesis 18: 159-166.